Summary financial information
This document includes summary financial information and should not be considered a substitute for our full financial statements, including footnotes, management/auditors’ reports, and related management’s discussion and analysis (MD&A). You can access our 2016 audited financial statements, MD&A and other annual disclosures in the “Investor Relations” section of our website, www.thomsonreuters.com, as well as in our filings with the Canadian securities regulatory authorities and the U.S. Securities and Exchange Commission.
Basis of presentation
Unless otherwise indicated, all amounts presented are from continuing operations and exclude the results of the IP & Science business, which was sold in October 2016. IP & Science was classified as a discontinued operation for 2016 reporting purposes.
Non-IFRS financial measures
We use certain unaudited non-IFRS financial measures. These measures include adjusted EBITDA and the related margin, adjusted EBITDA less capital expenditures, underlying operating profit and the related margin, free cash flow, free cash flow from ongoing businesses, adjusted EPS, selected measures before the impact of the fourth quarter 2016 charges, and revenue growth before the impact of currency. Non-IFRS financial measures are defined and reconciled to the most directly comparable IFRS measures in the annual review and our 2016 annual MD&A. We use these non-IFRS financial measures as supplemental indicators of our operating performance and financial position. These measures do not have any standardized meaning prescribed by IFRS and therefore are unlikely to be comparable to the calculation of similar measures used by other companies, and should not be viewed as alternatives to measures of financial performance calculated in accordance with IFRS.